Click Therapeutics said today that it landed a $17 million round, led by Sanofi‘s (NYSE:SNY)  venture arm, to fund its platform of prescription digital therapeutics. The company’s commercial product, Clickotine, is designed to help people quit smoking. The digital smoking cessation program uses a personalized plan to help people overcome tobacco cravings, adhere to medication […]